EFG International »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by EFG International

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by EFG International from 13F filings

Historical chart of EFG International investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by EFG International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by EFG International

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.6M 2.0M 1.28

More positions owned by EFG International

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Bank of America Corporation (BAC)
Applied Materials (AMAT)
Diamondback Energy (FANG)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for EFG International

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Steelhead Partners
Bnp Paribas Arbitrage, Snc
Alberta Investment Management Corporation
DeepCurrents Investment Group
State Street Corporation
CSS
FMR
BlackRock
MacKay Shields
Manufacturers Life Insurance Company
Bank of America Corporation
Bnp Paribas Investment Partners
Universal- Beteiligungs- und Servicegesellschaft mbH
Two Sigma Investments
Citigroup

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1